within Pharmacolibrary.Drugs.ATC.H;

model H01BA04
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00015,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00041999999999999996,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00023,
    k12             = 0.049,
    k21             = 0.049
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>H01BA04</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Terlipressin is a synthetic analog of vasopressin used primarily in the management of bleeding esophageal varices and hepatorenal syndrome in patients with liver cirrhosis. It is a prodrug, slowly metabolized to lysine vasopressin (the active form) and is administered intravenously. Terlipressin is approved and in use in several countries for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for adult patients with bleeding esophageal varices, both male and female, with impaired liver function. Intravenous administration.</p><h4>References</h4><ol><li><p>Nilsson, G, et al., &amp; Vernersson, E (1990). Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. <i>Drugs under experimental and clinical research</i> 16(6) 307–314. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2086166/\">https://pubmed.ncbi.nlm.nih.gov/2086166</a></p></li><li><p>Pesaturo, AB, et al., &amp; Voils, SA (2006). Terlipressin: vasopressin analog and novel drug for septic shock. <i>The Annals of pharmacotherapy</i> 40(12) 2170–2177. DOI:<a href=\"https://doi.org/10.1345/aph.1H373\">10.1345/aph.1H373</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17148649/\">https://pubmed.ncbi.nlm.nih.gov/17148649</a></p></li><li><p>Bateman, RM, et al., &amp; Prandi, E (2016). 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. <i>Critical care (London, England)</i> 20(Suppl 2) 94–None. DOI:<a href=\"https://doi.org/10.1186/s13054-016-1208-6\">10.1186/s13054-016-1208-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27885969/\">https://pubmed.ncbi.nlm.nih.gov/27885969</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end H01BA04;
